<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Connect Black LA | Sarms ligandrol 4033, oxandrolone pharmaceutical | Activity</title>
	<link>https://connectblackla.com/groups/sarms-ligandrol-4033-oxandrolone-pharmaceutical/</link>
	<atom:link href="https://connectblackla.com/groups/sarms-ligandrol-4033-oxandrolone-pharmaceutical/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the group, Sarms ligandrol 4033, oxandrolone pharmaceutical.</description>
	<lastBuildDate>Fri, 17 Apr 2026 11:34:30 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">aab3a3f3e425853b05f6f9ec0997db34</guid>
				<title>test title created the group Sarms ligandrol 4033, oxandrolone pharmaceutical</title>
				<link>https://connectblackla.com/activity/p/321/</link>
				<pubDate>Sun, 18 Dec 2022 09:19:57 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>